Fact-checked by Grok 2 weeks ago

Calcium signaling

Calcium signaling is the process by which calcium ions (Ca²⁺) act as a universal second messenger in eukaryotic cells, enabling the transduction of extracellular stimuli into intracellular responses that regulate essential physiological processes such as , release, , and . Under resting conditions, cytosolic free Ca²⁺ levels are tightly maintained at approximately 100 nM through active and mechanisms, preventing while allowing rapid transient elevations to 0.5–10 µM upon . These dynamic changes, often manifesting as localized , oscillations, or propagating waves, provide spatial and temporal specificity to signaling events. The importance of calcium signaling stems from its versatility and ubiquity, influencing nearly every aspect of cellular and organismal across kingdoms, from and fungi to animals. Dysregulation of Ca²⁺ is implicated in numerous pathologies, including cardiovascular diseases, neurodegenerative disorders, cancer, and immune dysfunction, underscoring its role as a therapeutic target. For instance, in excitable cells like neurons and cardiomyocytes, Ca²⁺ influx coordinates action potentials and , while in non-excitable cells, it modulates , , and . At the core of calcium signaling is a sophisticated toolkit comprising ion channels, pumps, exchangers, and buffers that generate, shape, and decode Ca²⁺ signals. Sources of Ca²⁺ include influx through plasma membrane channels (e.g., voltage-gated Ca²⁺ channels, store-operated channels like Orai1) and release from intracellular stores such as the (ER) via 1,4,5-trisphosphate receptors (IP₃Rs) or ryanodine receptors (RyRs). Sinks for Ca²⁺ removal involve pumps like the (SERCA) that sequester Ca²⁺ back into the ER, plasma membrane Ca²⁺-ATPases (PMCAs) that extrude it extracellularly, and mitochondrial uptake via the (MCU). Buffers such as and parvalbumin modulate free Ca²⁺ diffusion, ensuring signal localization in microdomains near channels or effectors. Signal specificity arises from the encoding of Ca²⁺ dynamics—amplitude, , , and —which are decoded by proteins and downstream effectors. For example, activates enzymes like Ca²⁺/-dependent II (CaMKII) for in neurons or myosin light chain kinase for contraction, while -modulated oscillations regulate transcription factors like NFAT in immune cells. Integration with other pathways, such as signaling or , further refines responses, highlighting Ca²⁺ as a crossroads for cellular . Advances in imaging and continue to reveal how contacts, like ER-mitochondria appositions, fine-tune these signals for and adaptation.

Fundamentals of Calcium Signaling

Definition and Biological Importance

Calcium signaling refers to transient elevations in the concentration of free calcium ions (Ca²⁺) within the of eukaryotic cells, which serve as a second messenger to convey signals from extracellular stimuli to intracellular targets, thereby eliciting diverse physiological responses. These dynamic changes in Ca²⁺ levels, often ranging from localized spikes to propagating waves, enable cells to integrate and decode environmental cues with high spatiotemporal precision.01531-0) The biological importance of Ca²⁺ as a signaling stems from its unique physicochemical properties and steep concentration gradients, which allow for rapid, amplified transmission without cellular . Under resting conditions, cytosolic free Ca²⁺ is maintained at a low level of approximately 100 nM, in stark contrast to the millimolar concentrations in the (1–2 mM) and within intracellular stores like the (up to 500 µM). This disequilibrium facilitates swift influx through channels upon stimulation, producing transient peaks of 0.5–10 µM that activate effectors while buffered systems prevent overload, as excess free Ca²⁺ could form insoluble phosphates or disrupt enzymatic functions. Consequently, Ca²⁺ orchestrates fundamental cellular processes, including , , and responses, with dysregulation implicated in diseases ranging from neurodegeneration to cancer.01531-0) Evolutionary conservation highlights Ca²⁺ signaling's universality, with core components present across eukaryotes from unicellular to multicellular humans, reflecting its ancient origins likely predating the divergence of and animal lineages over a billion years ago. In diverse organisms, it regulates critical functions such as flagellar motility in protists, vesicular secretion in fungi, and mitotic division in metazoans, demonstrating adaptability through specialized sensors and transporters. At the molecular level, Ca²⁺ exerts its effects by binding to target proteins, such as , inducing conformational changes that expose interaction sites and activate downstream enzymes like Ca²⁺/-dependent protein kinases and phosphatases, thereby translating ionic signals into biochemical cascades.01531-0)

Calcium Dynamics and Concentrations

Calcium signaling relies on precise control of intracellular calcium ion (Ca²⁺) concentrations, which are maintained at dramatically different levels across cellular compartments to enable specific signaling events. In the cytosol, the basal free Ca²⁺ concentration is typically around 100 nM (10⁻⁷ M), kept low by the action of Ca²⁺ pumps such as the sarco/endoplasmic reticulum Ca²⁺-ATPase (SERCA) and plasma membrane Ca²⁺-ATPase (PMCA), as well as by endogenous buffering systems that bind excess Ca²⁺ to prevent nonspecific activation of effectors.30147-5.pdf) In contrast, extracellular free Ca²⁺ levels are approximately 1–2 mM (10⁻³ M), creating a steep electrochemical gradient that drives Ca²⁺ influx upon channel opening. Within intracellular stores, the endoplasmic reticulum (ER) and sarcoplasmic reticulum (SR) maintain free Ca²⁺ concentrations in the range of 100 μM to 1 mM (10⁻⁴ to 10⁻³ M), achieved through active uptake mechanisms that counter leakage and support rapid release for signaling. To achieve spatial specificity in signaling, cells generate localized Ca²⁺ elevations known as microdomains, particularly near open channels or release sites. These microdomains can reach peak concentrations of 10–100 μM (up to 10⁻⁴ M) within nanometers of the source, far exceeding bulk cytosolic levels and allowing targeted activation of nearby effectors without global perturbations. A classic example is the Ca²⁺ spark, a brief, localized release event from ryanodine receptors (RyRs) in the , which forms a microdomain that propagates or integrates into broader signals while minimizing diffusion-based spread. Such restricted dynamics ensure that Ca²⁺ acts as a versatile second messenger, with microdomain amplitudes and durations tuned to the kinetics of individual channels. Buffering systems play a crucial role in shaping these Ca²⁺ signals by rapidly binding free ions, thereby controlling the spatiotemporal profile and preventing toxicity from overload. Intracellular proteins such as and parvalbumin, with dissociation constants (K_d) in the micromolar range, act as mobile buffers that reduce peak amplitudes and accelerate decay times, effectively filtering signals for downstream decoding. Exogenous chelators like BAPTA mimic this by similarly modulating transients, highlighting the buffers' capacity to tune signal fidelity. The relationship between free and total Ca²⁺ can be approximated under conditions where buffer concentration greatly exceeds free Ca²⁺: [\ce{Ca^{2+}}]_{\text{free}} \approx \frac{[\ce{Ca^{2+}}]_{\text{total}}}{1 + \frac{[\ce{B}]_{\text{total}}}{[K_d](/page/Dissociation_constant)}} where [\ce{B}]_{\text{total}} is the total buffer concentration and K_d is the buffer's . This equation illustrates how high-affinity buffers (low K_d) enhance control over transient rises. Beyond static , dynamic patterns such as Ca²⁺ and oscillations encode information through variations in frequency and amplitude, allowing cells to distinguish stimuli. Waves propagate as regenerative releases across the or between cells via gap junctions, with speed and extent modulated by local buffering and . Oscillations, often driven by periodic store release and uptake, convey signals via (e.g., higher rates activating proliferation pathways) or (e.g., larger peaks triggering ), enabling analog-digital processing in diverse contexts like neuronal firing or . These patterns underscore Ca²⁺'s role in , with buffering systems further refining the to match effector sensitivities.

Mechanisms of Calcium Regulation

Intracellular Calcium Stores and Release

The primary intracellular reservoirs for calcium ions (Ca²⁺) are the (ER) in non-muscle cells and the (SR) in muscle cells, where free luminal Ca²⁺ concentrations reach approximately 0.2–1 mM, far exceeding cytosolic levels of around 100 nM. These organelles maintain Ca²⁺ by sequestering ions against steep electrochemical gradients, enabling rapid mobilization for signaling. The ER and SR are loaded with Ca²⁺ via sarco/ Ca²⁺-ATPase (SERCA) pumps, which utilize to transport two Ca²⁺ ions per cycle into the while counter-transporting protons, with SERCA isoforms varying by tissue—such as SERCA2a in cardiac SR and SERCA1a in fast-twitch . Calcium release from ER/SR stores primarily occurs through two families of ligand-gated channels: inositol 1,4,5-trisphosphate receptors (IP₃Rs) and ryanodine receptors (RyRs). IP₃Rs form tetrameric structures, each subunit spanning the membrane six times with a central ion pore and large N-terminal cytoplasmic domains that bind IP₃ and regulatory factors. Activation requires binding of IP₃ to its receptor site, which promotes a conformational change transmitted to the pore, but full channel opening depends on cytosolic Ca²⁺ as a co-agonist; IP₃R activity displays a characteristic bell-shaped dose-response to Ca²⁺, with potentiation at submicromolar concentrations (via Ca²⁺-binding sites in the regulatory domain) and inhibition at higher levels (above 10 μM) due to Ca²⁺ occlusion or allosteric effects. Three IP₃R isoforms (IP₃R1–3) exist, with tissue-specific expression—IP₃R1 dominant in brain and cerebellum—allowing nuanced control of release in non-excitable cells. RyRs, the largest known ion channels at over 2 MDa, also assemble as tetramers with extensive cytoplasmic domains (about 70% of their mass) that interact with accessory proteins like FKBP and sensors for Ca²⁺, state, and . Three mammalian isoforms are recognized: RyR1, enriched in SR where it couples to dihydropyridine receptors for excitation-contraction coupling; RyR2, predominant in cardiac SR for propagating Ca²⁺ waves during ; and RyR3, expressed at lower levels in , , and developing , contributing to finer spatial Ca²⁺ control. RyR gating is modulated by cytosolic Ca²⁺ (promoting Ca²⁺-induced Ca²⁺ release, or CICR, at 1–10 μM), inhibitory Mg²⁺ (competing at Ca²⁺ sites), and —such as by at Ser-2808 on RyR2, which sensitizes the channel—allowing amplification of local signals into global transients. Release through IP₃Rs and RyRs is often quantal, manifesting as discrete elementary events rather than uniform efflux, which ensures signaling fidelity and prevents overload. IP₃R clusters generate local Ca²⁺ puffs—brief (tens of milliseconds), localized elevations (1–10 μM) from 1–10 channels—while RyR arrays in SR produce Ca²⁺ , similar in scale but typically faster and more synchronized in muscle dyads. These events, detected via , reflect probabilistic channel recruitment and feedback, with puffs propagating into waves under sustained IP₃ stimulation and sparks underpinning beat-to-beat Ca²⁺ cycling in cardiomyocytes. Store depletion from such releases can secondarily activate plasma membrane channels to replenish ER/SR Ca²⁺ via store-operated entry.

Plasma Membrane Calcium Channels and Entry

Calcium entry across the plasma membrane represents a primary mechanism for elevating intracellular Ca²⁺ levels in response to extracellular stimuli, enabling signaling cascades in excitable and non-excitable cells alike. These channels permit selective influx of Ca²⁺ ions from the extracellular milieu, where concentrations reach 1–2 mM, into the maintained at ~100 nM under resting conditions. This gradient drives rapid and localized Ca²⁺ transients that propagate signals for processes such as neurotransmitter release and . Voltage-gated Ca²⁺ channels (VGCCs) transduce membrane into Ca²⁺ influx and are subdivided into families based on thresholds and . The L-type channels (Caᵥ1.1–Caᵥ1.4) activate at depolarized potentials around -20 , exhibiting sustained currents that support prolonged signaling. In contrast, T-type channels (Caᵥ3.1–Caᵥ3.3) activate at more hyperpolarized levels near -60 , generating transient bursts ideal for activity. VGCCs achieve high selectivity for Ca²⁺ over monovalent cations like Na⁺ through negatively charged glutamate residues in the selectivity filter of the pore-forming α₁ subunit. The reversal potential (E_rev) for Ca²⁺ through these channels approximates +120 mV, dictated by the reflecting the steep :
E_{\mathrm{Ca}} = \frac{RT}{2F} \ln \left( \frac{[\mathrm{Ca}^{2+}]_{\mathrm{o}}}{[\mathrm{Ca}^{2+}]_{\mathrm{i}}} \right)
where R is the , T is , F is Faraday's constant, and [Ca²⁺]ₒ and [Ca²⁺]ᵢ are extracellular and intracellular concentrations, respectively. The Ca²⁺ current is governed by the ohmic relation:
I_{\mathrm{Ca}} = g_{\mathrm{Ca}} (V - E_{\mathrm{Ca}})
with g_Ca denoting conductance, V the , and E_Ca the reversal potential; this formulation underpins biophysical models of VGCC function.
Ligand-gated Ca²⁺ channels provide an alternative entry route triggered by specific extracellular messengers. In neurons, N-methyl-D-aspartate (NMDA) receptors function as ligand-gated channels activated by co-agonists glutamate (EC₅₀ ≈ 1 μM) and , forming tetramers of GluN1 and GluN2 subunits that permit substantial Ca²⁺ permeability (P_Ca/P_Na ≈ 10). This influx, peaking at ~0.5 mM in dendritic spines within milliseconds, drives and . Transient receptor potential (TRP) channels, particularly the canonical subfamily (TRPC1–7), mediate Ca²⁺ entry in diverse tissues, often activated by ligands like diacylglycerol or in response to store depletion signals; they exhibit moderate Ca²⁺ selectivity (P_Ca/P_Na = 0.1–20) and form homotetramers or heteromers with a central pore. Plasma membrane Ca²⁺ influx via these channels not only initiates direct downstream signaling—such as calpain activation for or NFAT-mediated transcription in muscle—but also replenishes depleted intracellular stores to sustain oscillatory dynamics. For instance, VGCC- and TRPC-mediated entry restores Ca²⁺ levels in , countering fatigue from repetitive stimulation. Pharmacological modulation targets these pathways selectively; dihydropyridines (e.g., amlodipine, ) bind L-type VGCCs at the α₁ subunit, inhibiting influx with high potency (IC₅₀ ≈ 1–10 nM) and minimal effects on other subtypes at therapeutic doses.

Calcium Pumps and Extrusion Systems

Calcium pumps and extrusion systems are essential mechanisms that maintain low cytosolic Ca²⁺ concentrations by sequestering or expelling Ca²⁺ following signaling events, thereby terminating signals and enabling cellular . These systems include ATP-driven pumps and secondary active transporters that operate against steep concentration gradients, ensuring rapid restoration of resting Ca²⁺ levels around 100 nM. The sarco/endoplasmic reticulum Ca²⁺-ATPase (SERCA) pumps are integral membrane proteins that actively uptake Ca²⁺ into the (ER) or (SR) using ATP hydrolysis. Encoded by three genes (ATP2A1, ATP2A2, ATP2A3), SERCA exists in multiple isoforms: SERCA1 (primarily in fast-twitch , with adult SERCA1a and neonatal SERCA1b variants), SERCA2 (ubiquitous, including cardiac-specific SERCA2a and housekeeping SERCA2b), and SERCA3 (predominant in non-muscle tissues like hematopoietic cells, with six splice variants). Each cycle transports two Ca²⁺ ions into the against a gradient while countertransporting protons, driven by conformational changes from a high-affinity E1 state to a low-affinity E2 state. In muscle cells, SERCA2a activity is inhibited by phospholamban, which binds to the pump's cytosolic domain and reduces Ca²⁺ affinity; phosphorylation of phospholamban by or Ca²⁺/calmodulin-dependent kinase relieves this inhibition, enhancing uptake velocity. The plasma membrane Ca²⁺-ATPase (PMCA) extrudes Ca²⁺ from the to the , functioning as a high-affinity, low-capacity pump critical for fine-tuning Ca²⁺ signals. Encoded by four genes (ATP2B1-4), PMCA isoforms exhibit tissue-specific expression—PMCA1 and PMCA4 are ubiquitous, while PMCA2 and PMCA3 are enriched in and other excitable tissues—with alternative splicing generating up to 30 variants that modulate activity. PMCA operates via , transporting one Ca²⁺ outward per cycle, and in most isoforms, it is coupled to H⁺ influx in a 1:1 , making the process partially electroneutral. binding to the C-terminal autoinhibitory domain activates PMCA, lowering the Ca²⁺ K_d from ~10-20 μM to <1 μM, thus enabling efficient extrusion even at low cytosolic Ca²⁺ levels. The Na⁺/Ca²⁺ exchanger (NCX), a secondary active transporter, facilitates Ca²⁺ extrusion using the Na⁺ electrochemical gradient established by the Na⁺/K⁺-ATPase. Predominantly expressed in excitable cells like cardiomyocytes, NCX operates in forward mode (3 Na⁺ in: 1 Ca²⁺ out) to extrude Ca²⁺ during relaxation or in reverse mode (3 Na⁺ out: 1 Ca²⁺ in) under depolarizing conditions, with the 3:1 stoichiometry rendering the process electrogenic and generating a net inward current of one positive charge per cycle. This reversibility allows NCX to contribute ~30% of Ca²⁺ removal in ventricular myocytes, with a turnover rate up to 5000 ions per second and a K_m for intracellular Ca²⁺ of ~6 μM. Three isoforms (NCX1-3) exist, with NCX1 being the cardiac predominant form. The activity of these pumps and exchangers follows Michaelis-Menten kinetics, where the transport rate V is given by V = V_{\max} \frac{[\ce{Ca^{2+}}]}{K_m + [\ce{Ca^{2+}}]} with V_{\max} representing the maximum velocity and K_m the Ca²⁺ concentration at half-maximal rate, typically in the micromolar range for SERCA and PMCA to ensure saturation during signaling spikes. This hyperbolic dependence allows efficient operation across physiological Ca²⁺ fluctuations.

Key Signaling Pathways

Phospholipase C and IP3 Pathway

The phospholipase C (PLC) and inositol 1,4,5-trisphosphate (IP₃) pathway represents a primary receptor-initiated mechanism for mobilizing intracellular calcium stores in response to extracellular signals. G protein-coupled receptors (), such as those activated by hormones, neurotransmitters, or growth factors, couple to the heterotrimeric G protein upon ligand binding. This coupling leads to the exchange of GDP for GTP on the Gαq subunit, which dissociates and directly activates isoforms of PLCβ at the plasma membrane. Activated PLCβ then hydrolyzes the minor plasma membrane phospholipid (PIP₂) into two second messengers: the water-soluble (IP₃) and the lipid-soluble (DAG). This enzymatic reaction is depicted as: \text{PIP}_2 \xrightarrow{\text{PLC}} \text{IP}_3 + \text{DAG} The rate of PIP₂ hydrolysis is governed by the concentration of active PLCβ and the availability of PIP₂ substrate, allowing for rapid signal amplification in stimulated cells. DAG remains embedded in the membrane to activate , while IP₃ diffuses freely through the cytosol to reach intracellular targets. IP₃ binds with high affinity to IP₃ receptors (IP₃Rs), which are tetrameric ligand-gated calcium channels embedded in the endoplasmic reticulum (ER) membrane. Binding of IP₃ to the N-terminal ligand-binding domain of each IP₃R subunit induces a conformational change that, in the presence of cytosolic calcium, opens the central ion pore, enabling the release of stored Ca²⁺ from the ER lumen into the cytoplasm. This release generates localized calcium transients or global waves, with signal amplification occurring as released Ca²⁺ sensitizes nearby IP₃Rs, propagating the response across the cell. The IP₃R structure includes regulatory domains for both IP₃ and Ca²⁺, facilitating this coordinated gating. PLC exists in multiple isoforms tailored to different activation modes: PLCβ (isoforms 1–4) is predominantly activated by Gq-coupled GPCRs through direct interaction with Gαq-GTP, while PLCγ (isoforms 1 and 2) is activated downstream of receptor tyrosine kinases via phosphorylation on tyrosine residues. These isoforms are subject to feedback regulation by calcium ions, where modest increases in cytosolic enhance PLC activity to boost IP₃ production and sustain signaling, but higher levels inhibit certain isoforms to prevent overload, ensuring oscillatory or pulsatile calcium dynamics.

Ryanodine Receptors and CICR

Calcium-induced calcium release (CICR) is a fundamental amplification mechanism in calcium signaling, where a small influx of Ca²⁺ into the cytosol triggers the opening of (RyRs) on the (SR), leading to the release of a much larger amount of stored Ca²⁺. This process creates regenerative Ca²⁺ waves or transients that propagate signaling events. In cardiac myocytes, for instance, the initial Ca²⁺ entry through (VGCCs) during membrane depolarization activates RyRs, facilitating the rapid rise in cytosolic Ca²⁺ necessary for contraction. RyRs are large homotetrameric ion channels that exhibit bidirectional sensitivity to for gating, with activation occurring at low micromolar concentrations (around 1–10 μM) via high-affinity binding sites on the cytosolic face, while higher concentrations (above 100 μM) promote inactivation through lower-affinity inhibitory sites. This biphasic regulation ensures precise control, preventing uncontrolled release while allowing amplification. The cardiac isoform, , is further modulated by the immunophilin , which binds to the channel and stabilizes its closed state, reducing open probability and subconductance events to maintain coordinated release; dissociation of , often under stress conditions, can lead to leaky channels and dysregulated CICR. In physiological contexts, CICR via RyRs is predominant in cardiac muscle, where it underlies excitation-contraction coupling by synchronizing Ca²⁺ sparks—elementary release events from RyR clusters—into global transients that drive systole. Pathologically, RyR2 hyperactivity or mutations can provoke spontaneous Ca²⁺ waves, contributing to arrhythmias such as ventricular tachycardia and sudden cardiac death by triggering delayed afterdepolarizations. Mathematical modeling of CICR often employs local control theory, where release is confined to dyadic subspaces near VGCCs, as proposed by Stern. A basic representation of cytosolic Ca²⁺ dynamics incorporates CICR flux as: \frac{d[\ce{Ca}]}{dt} = J_{\text{in}} - J_{\text{out}} + J_{\text{CICR}} where J_{\text{CICR}} = k \cdot [\ce{Ca}]_{\text{local}} \cdot P_{\text{open}}(\text{RyR}), with k as a scaling factor, [\ce{Ca}]_{\text{local}} the local trigger Ca²⁺ concentration, and P_{\text{open}} the RyR open probability dependent on Ca²⁺ binding. This framework highlights how stochastic RyR gating and feedback yield graded release despite high gain.

Store-Operated Calcium Entry

Store-operated calcium entry (SOCE) is a critical mechanism that replenishes intracellular calcium stores by facilitating Ca²⁺ influx across the plasma membrane in response to depletion of endoplasmic reticulum (ER) Ca²⁺ levels. This process is mediated by the interaction between stromal interaction molecules ( and ) in the ER and channels in the plasma membrane, forming the core of the SOCE machinery. Upon ER Ca²⁺ store depletion, typically triggered by signals such as inositol 1,4,5-trisphosphate ()-induced release, STIM proteins sense the reduced luminal Ca²⁺ and initiate a signaling cascade to activate ORAI channels. The mechanism begins with STIM1 and STIM2, which are single-pass transmembrane proteins localized in the ER membrane with their Ca²⁺-binding EF-hand domains facing the ER lumen. When ER Ca²⁺ levels drop, the luminal EF-SAM domain of STIM1/2 loses Ca²⁺ binding, leading to a conformational change that exposes a STIM-ORAI activation region (SOAR). This triggers oligomerization of STIM proteins into higher-order complexes, which translocate to ER-plasma membrane (ER-PM) junctions known as puncta. At these sites, STIM1 directly binds to and gates ORAI1 channels, opening them to allow Ca²⁺ influx. STIM1 activation occurs with a conformational change threshold when the ER Ca²⁺ concentration ([Ca²⁺]ₑᵣ) falls below approximately 200 μM, ensuring precise sensing of store depletion. ORAI proteins, particularly ORAI1, form the pore-forming subunits of store-operated Ca²⁺ release-activated Ca²⁺ (CRAC) channels, which mediate SOCE with exceptional Ca²⁺ selectivity. ORAI1 forms a hexameric channel, with each subunit having four transmembrane segments, where the selectivity filter in the pore loop confers high selectivity for Ca²⁺ over other ions, achieving a permeability ratio of Ca²⁺ to Na⁺ greater than 1000:1. The resulting current, I_CRAC, is characterized by strong inward rectification, meaning it conducts more effectively at negative membrane potentials while exhibiting minimal outward current at positive potentials, which helps maintain low cytosolic Ca²⁺ levels during influx. This rectification arises from voltage-dependent block by intracellular Mg²⁺ and the channel's intrinsic gating properties. Physiologically, SOCE provides sustained Ca²⁺ entry essential for long-term signaling processes, such as the activation of the transcription factor in immune cells. Ca²⁺ influx through CRAC channels activates , which dephosphorylates NFAT, promoting its nuclear translocation and gene expression for cytokine production and T-cell activation. Pharmacologically, SOCE is inhibited by compounds like 2-aminoethoxydiphenyl borate (2-APB), which at concentrations around 50-100 μM blocks ORAI1 gating by interfering with STIM1-ORAI1 coupling, thereby attenuating sustained Ca²⁺ signals.

Physiological Roles

Excitation-Contraction Coupling in Muscle

Excitation-contraction coupling (ECC) in muscle cells translates electrical signals from action potentials into mechanical force through orchestrated calcium signaling, primarily involving the sarcoplasmic reticulum (SR) as the key intracellular store. In both skeletal and cardiac muscle, depolarization of the plasma membrane activates voltage-gated calcium channels (VGCCs), leading to calcium release from the SR via ryanodine receptors (RyRs), which then binds to troponin C to facilitate actin-myosin interactions. This process ensures rapid and precise control of contraction, with distinct mechanisms in skeletal versus cardiac muscle reflecting their physiological demands for sustained versus rhythmic activity. In skeletal muscle, ECC begins with the propagation of an action potential along the sarcolemma and into the transverse tubules (T-tubules), causing depolarization that activates dihydropyridine receptors (DHPRs), which are L-type VGCCs (CaV1.1) embedded in the T-tubule membrane. The conformational change in DHPRs mechanically couples to and gates channels in the SR membrane, triggering Ca²⁺ release through direct physical interaction rather than significant calcium influx. The released Ca²⁺ diffuses to the myofibrils and binds to on the thin filaments, inducing a conformational change that displaces , exposing myosin-binding sites on and enabling cross-bridge cycling for contraction. This direct orthograde signaling via DHPR-RyR1 tetrads ensures efficient, voltage-dependent activation without reliance on substantial extracellular calcium entry. Cardiac muscle employs a similar yet distinct ECC mechanism, where T-tubule and surface membrane opens L-type VGCCs (CaV1.2), allowing a small influx of extracellular Ca²⁺ that directly triggers RyR2-mediated CICR from the , amplifying the signal for a robust systolic calcium transient. Unlike , this process depends heavily on the calcium entry through L-type channels to initiate RyR2 opening, with fractional SR calcium release typically ranging from 20-40% of total SR content per beat, ensuring graded force modulation based on duration and calcium load. The released Ca²⁺ similarly binds to promote , but the reliance on CICR allows for dynamic regulation by sympathetic stimulation and calcium handling proteins. Muscle relaxation is achieved by rapidly lowering cytosolic Ca²⁺ levels, primarily through the action of sarco/endoplasmic reticulum Ca²⁺-ATPase () pumps, which reuptake Ca²⁺ into the , allowing to release Ca²⁺ and to re-inhibit actin-myosin interactions. In , SERCA activity is regulated by phospholamban (PLN), which inhibits SERCA by reducing its affinity for Ca²⁺; phosphorylation of PLN by (PKA) or Ca²⁺/calmodulin-dependent protein kinase II (CaMKII) relieves this inhibition, accelerating reuptake and enhancing relaxation rates, particularly during β-adrenergic stimulation in the heart. In , SERCA is regulated differently, often by sarcolipin in fast-twitch fibers. This regulatory loop ensures timely diastolic relaxation and prepares the muscle for subsequent contractions. The relationship between calcium concentration and contractile force in muscle follows the Hill equation, reflecting the cooperative binding of Ca²⁺ to : \text{Force} \propto \frac{[\ce{Ca^{2+}}]^n}{K + [\ce{Ca^{2+}}]^n} where n is the Hill coefficient (approximately 4, indicating strong due to multiple Ca²⁺ binding sites on ) and K is the half-activation constant. This relationship allows for sensitive force modulation over a narrow physiological range of Ca²⁺ concentrations.

Synaptic Transmission and Neuroplasticity

In synaptic transmission, calcium ions (Ca²⁺) orchestrate the rapid release of at presynaptic terminals. Upon arrival of an , activates voltage-gated calcium channels (VGCCs), primarily P/Q-type (Caᵥ2.1) and N-type (Caᵥ2.2), which are clustered at the active zone to permit localized Ca²⁺ influx. This influx, occurring within microseconds, elevates cytosolic Ca²⁺ concentration to micromolar levels near docked synaptic vesicles. The Ca²⁺ sensor synaptotagmin-1 then binds Ca²⁺ with high affinity, relieving inhibition on the SNARE complex (comprising syntaxin-1, SNAP-25, and VAMP2/synaptobrevin) and driving the zipper-like assembly that fuses the vesicle membrane with the plasma membrane, enabling quantal neurotransmitter release into the synaptic cleft. The probability of vesicular release (P_r) depends steeply on presynaptic Ca²⁺ levels, reflecting cooperative binding requirements for exocytosis. This relationship is quantitatively captured by the Dodge-Rahamimoff model, where release probability follows: P_r = 1 - \exp\left(-k [\mathrm{Ca}^{2+}]^n\right) with n ≈ 4 for many synapses, indicating a fourth-power dependence that amplifies small changes in Ca²⁺ into large variations in synaptic output and thus quantal content. This nonlinearity ensures reliable transmission during high-frequency firing while allowing modulation of synaptic efficacy. Postsynaptically, Ca²⁺ entry through NMDA receptors, activated by coincident presynaptic glutamate release and postsynaptic , initiates signaling cascades for . The influx activates calcium/calmodulin-dependent II (CaMKII), which autophosphorylates at Thr286 to persist in an active state even after Ca²⁺ levels decline. Active CaMKII phosphorylates the GluA1 subunit of receptors at Ser831, promoting their phosphorylation-dependent trafficking from intracellular stores to the postsynaptic density via interactions with transmembrane AMPA receptor regulatory proteins (TARPs) and remodeling. This insertion enhances postsynaptic receptor-mediated currents, underpinning the early phase of (LTP) and synaptic strengthening. In , patterns of postsynaptic Ca²⁺ dynamics—such as frequency, amplitude, and duration of transients—differentially encode -specific modifications. High-frequency stimulation induces large, prolonged Ca²⁺ elevations that favor CaMKII activation and LTP, promoting strengthening through potentiation and spine enlargement. Conversely, lower-frequency inputs generate smaller or more transient Ca²⁺ signals that preferentially activate the phosphatase (PP2B), which dephosphorylates targets like GluA1 at Ser845, facilitating endocytosis and long-term depression () for weakening. These bidirectional Ca²⁺-dependent pathways enable adaptive circuit refinement, with oscillations in Ca²⁺ serving as a temporal code for distinguishing potentiation from depression based on stimulation history.

Fertilization and Egg Activation

In fertilization, the entry of sperm into the mature initiates a cascade of calcium (Ca²⁺) signals that activate the egg and prevent further sperm penetration, marking the onset of embryonic development. These signals manifest as repetitive Ca²⁺ elevations from intracellular stores in the (ER), which are critical for coordinating multiple activation events. Unlike sustained Ca²⁺ rises in other cellular processes, the oscillatory nature of these signals in reproductive contexts ensures precise temporal control over downstream responses. The primary mechanism driving these Ca²⁺ oscillations involves the sperm-specific enzyme phospholipase C zeta (PLCζ), a soluble factor released into the cytoplasm upon fusion. PLCζ catalyzes the hydrolysis of (PIP₂) in the plasma membrane to generate inositol 1,4,5-trisphosphate (IP₃), which diffuses to bind and activate IP₃ receptors (IP₃Rs) on the , triggering Ca²⁺ release into the . This initiates a series of oscillations mediated by IP₃R1, the predominant isoform in mammalian oocytes, with characteristic frequencies of 1–5 minutes per transient—such as ~3 minutes in hamsters and ~50 minutes in cows—persisting for several hours to encode species-specific activation patterns. The oscillations arise from the dynamic interplay of IP₃ production, Ca²⁺-sensitive feedback on PLCζ activity, and periodic replenishment of stores. A key feature of these signals is the propagation of Ca²⁺ waves from the injection site across the . This occurs through the diffusion of IP₃, which sensitizes adjacent IP₃Rs, combined with calcium-induced calcium release (CICR), where initial cytosolic Ca²⁺ elevations amplify release from neighboring regions via positive feedback on IP₃Rs. In mammals, this results in repeated wavelike transients that sweep the oocyte perimeter; by contrast, species such as sea urchins exhibit a single, rapid Ca²⁺ wave lasting 1–2 minutes, also IP₃-mediated but without prolonged oscillations. These variations highlight evolutionary adaptations in Ca²⁺ signaling to suit reproductive strategies across phyla. The physiological outcomes of these Ca²⁺ oscillations are essential for successful egg activation. A single early transient induces of cortical granules, releasing enzymes that harden the and block by modifying receptor proteins. Subsequent oscillations, typically requiring at least four transients, activate calcium/calmodulin-dependent II (CaMKII), which phosphorylates targets to resume from II arrest, extrude the second , form male and female pronuclei, and recruit stored maternal mRNAs for zygotic genome activation. Disruptions in oscillation frequency or can impair these processes, underscoring their role in developmental fidelity.

Gene Expression and Cell Proliferation

Calcium signaling plays a pivotal role in regulating and by modulating transcription factors through sustained intracellular Ca²⁺ elevations. In particular, sustained Ca²⁺ entry, often mediated by store-operated calcium entry (SOCE), activates the phosphatase , which dephosphorylates nuclear factor of activated T cells (NFAT) proteins. This dephosphorylation enables NFAT nuclear translocation, where it binds to promoter regions of target genes, including those encoding cytokines such as interleukin-2 (IL-2), thereby driving immune responses in activated T cells. The activation of NFAT is highly sensitive to the duration and amplitude of Ca²⁺ signals, with sustained elevations above a threshold level required for efficient binding and NFAT . This pathway can be modeled simply as NFAT activity being proportional to the sustained Ca²⁺ concentration relative to the calcineurin activation threshold: \text{NFAT activity} \propto \frac{[\ce{Ca^{2+}}]_{\text{sustained}}}{\text{threshold for calcineurin activation}} Such modeling highlights how prolonged Ca²⁺ influx ensures robust transcriptional output. In the context of cell proliferation, Ca²⁺ binds to calmodulin (CaM), forming a complex that activates Ca²⁺/calmodulin-dependent protein kinases (CaMKs), particularly CaMKII and CaMKIV. These kinases phosphorylate the transcription factor CREB at serine 133, promoting its binding to CRE elements in the promoters of immediate early genes like c-fos, which is essential for cell cycle progression. In T cells, this Ca²⁺-CaM-CaMK-CREB axis synergizes with NFAT to induce proliferative genes during activation, facilitating clonal expansion. Dysregulation of this pathway contributes to uncontrolled proliferation in cancers, where elevated CaMK activity drives oncogenic transcription and tumor growth. Ca²⁺ signals often occur as oscillations, and their frequency is decoded by downstream effectors to selectively activate programs. High-frequency Ca²⁺ oscillations preferentially stimulate proliferation-associated genes through enhanced of transcription factors like CREB and , while lower frequencies favor pathways. This frequency-dependent decoding allows cells to integrate temporal Ca²⁺ dynamics into precise proliferative responses, as seen in immune and contexts.

Pathophysiology and Dysregulation

Calcium Signaling in Disease

Dysregulated calcium (Ca²⁺) signaling plays a central role in numerous pathologies by disrupting cellular , leading to aberrant activation of downstream effectors such as enzymes, transcription factors, and ion channels. In neurodegenerative disorders, altered Ca²⁺ fluxes contribute to neuronal toxicity and synaptic dysfunction. For instance, in , amyloid-β (Aβ) oligomers disrupt inositol 1,4,5-trisphosphate receptors (IP₃Rs) on the (), resulting in excessive Ca²⁺ release and ER Ca²⁺ overload, which exacerbates mitochondrial dysfunction and neuronal death. Similarly, in , hyperactivity of ryanodine receptors (RyRs) leads to dysregulated Ca²⁺ release from the ER, promoting striatal neuronal vulnerability and contributing to motor and cognitive deficits. In cardiovascular diseases, genetic alterations in Ca²⁺ handling proteins directly precipitate life-threatening arrhythmias and vascular dysfunction. Mutations in the RyR2 gene, which encodes the cardiac ryanodine receptor, cause catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited arrhythmia syndrome characterized by exercise- or stress-induced ventricular tachyarrhythmias due to aberrant diastolic Ca²⁺ leaks from the sarcoplasmic reticulum. Additionally, defects in plasma membrane Ca²⁺-ATPase 1 (PMCA1), such as reduced expression, are associated with hypertension by impairing Ca²⁺ extrusion from vascular smooth muscle cells, leading to elevated intracellular Ca²⁺ levels and increased vascular tone. Cancer progression is profoundly influenced by upregulated Ca²⁺ entry pathways that fuel , , and . Overexpression of ORAI1, a key component of store-operated Ca²⁺ entry (SOCE), enhances Ca²⁺ influx in various malignancies, promoting turnover and ; for example, in colorectal and cancers, elevated ORAI1 correlates with metastatic potential. Transient receptor potential (TRP) channels, particularly TRPC1 and TRPV6, also drive cancer cell by facilitating sustained Ca²⁺ influx that activates pro-survival signaling cascades like and MAPK pathways in and tumors. A landmark insight into Ca²⁺ signaling defects arose from studies on (SCID), where loss-of-function mutations in ORAI1, the pore subunit of Ca²⁺ release-activated Ca²⁺ (CRAC) channels, were identified in 2006, abolishing SOCE in T cells and revealing the essential role of CRAC channels—first characterized in the —in immune function.

Therapeutic Targeting of Calcium Pathways

Therapeutic targeting of calcium signaling pathways has emerged as a promising strategy for treating various diseases where dysregulated Ca²⁺ homeostasis contributes to pathology, such as cardiovascular disorders, cancer, and immune-mediated conditions. By modulating key components like voltage-gated calcium channels (VGCCs), store-operated calcium entry (SOCE) mechanisms, and Ca²⁺ pumps, pharmacological agents can restore balance and mitigate disease progression. These interventions often aim to inhibit excessive Ca²⁺ influx or enhance Ca²⁺ sequestration, with several compounds advancing to clinical use or trials. Calcium channel blockers targeting L-type VGCCs represent a cornerstone of cardiovascular therapeutics. , a non-dihydropyridine L-type VGCC blocker, is widely used to treat chronic stable by reducing myocardial oxygen demand through and negative effects. Similarly, , another L-type blocker with enhanced cerebrovascular selectivity, is administered to prevent delayed cerebral ischemia following , a condition linked to , by improving cerebral blood flow and reducing . These agents exemplify how selective inhibition of VGCCs can provide symptomatic relief in Ca²⁺-dependent vascular and cardiac pathologies. Inhibitors of SOCE, which mediate Ca²⁺ influx upon store depletion via channels, are under investigation for inflammatory and neoplastic diseases. Auxora (CM4620), a selective SOCE inhibitor, has demonstrated efficacy in preclinical models of by suppressing pathological Ca²⁺ signaling in pancreatic acinar cells and is in clinical trials (e.g., Phase II) for this indication due to its favorable safety profile. For immune disorders, anti-1 antibodies such as DS-2741a have been investigated in preclinical models for targeted suppression of T-cell and activation by blocking CRAC channel function, potentially reducing aberrant immune responses in allergic conditions without broad . Modulators of Ca²⁺ pumps, particularly the sarco/ Ca²⁺-ATPase (), provide dual opportunities for enhancing or inhibiting Ca²⁺ handling. , a potent , disrupts ER Ca²⁺ stores to induce selectively in cancer cells, and prodrug derivatives conjugated to tumor-targeting peptides are in for and other cancers to minimize off-target toxicity. Conversely, istaroxime acts as a 2a agonist and Na⁺/K⁺- , improving cardiac contractility and relaxation in models; as of June 2025, ongoing Phase II trials (SEISMiC Extension) have met enrollment targets for interim analysis in , showing potential to address systolic dysfunction without the arrhythmias associated with traditional inotropes. Emerging therapies leverage genetic interventions to correct Ca²⁺ pathway defects. targeting (RyR) mutations, common in (CPVT), includes /Cas9-mediated editing of the RYR2 gene, which has corrected arrhythmogenic Ca²⁺ leak in preclinical mouse models, restoring normal excitation-contraction coupling. In , advances in the 2020s focus on phospholipase C zeta (PLCζ), a sperm-specific essential for activation; recombinant PLCζ protein shows promise as an assisted activation agent in for male infertility cases with PLCζ deficiencies, improving fertilization rates in clinical settings.

References

  1. [1]
    Calcium Signaling Mechanisms Across Kingdoms - Annual Reviews
    Oct 6, 2021 · Calcium (Ca2+) is a unique mineral that serves as both a nutrient and a signal in all eukaryotes. To maintain Ca2+ homeostasis for both ...
  2. [2]
    Fundamentals of Cellular Calcium Signaling: A Primer - PMC
    This primer discusses basic principles and mechanisms underlying cellular Ca 2+ signaling and Ca 2+ homeostasis.
  3. [3]
    Calcium signalling: dynamics, homeostasis and remodelling - Nature
    Jul 1, 2003 · This review concentrates on the nature of the Ca2+-signalling toolkit and how it is exploited to create many different Ca2+-signalling systems.Missing: article | Show results with:article
  4. [4]
    Physiology, Calcium - StatPearls - NCBI Bookshelf - NIH
    Calcium is essential for bone strength and is stored in bone. It exists in serum in three forms and is used for muscle contraction and other functions.
  5. [5]
  6. [6]
    Extracellular Calcium Sensing and Extracellular Calcium Signaling
    A great deal has occurred in the field of extracellular Ca2+ (Cao 2+) sensing since 1991 when an earlier article in Physiological Reviews addressed this subject ...
  7. [7]
    Endoplasmic Reticulum Ca2+ Handling in Excitable Cells in Health ...
    Much of the Ca2+ in the ER is in a free, unbuffered state; although the total store content may exceed 1 mM in some cells, estimates of free [Ca2+] range from ...
  8. [8]
    Calcium Sparks | Physiological Reviews
    Ample evidence shows that Ca 2+ sparks catalyze many high-threshold Ca 2+ processes involved in cardiac and skeletal muscle excitation-contraction coupling.
  9. [9]
    Calcium buffering properties of calbindin D28k and parvalbumin in ...
    We have examined the ability of the Ca(2+)-binding proteins (CABP) calbindin D28k and paravalbumin to modulate increases in the intracellular free Ca2+ ...
  10. [10]
    Physiology of intracellular calcium buffering
    The degree of buffering depends on factors such as the affinity for Ca2+, the Ca2+ concentration, and whether Ca2+ ions bind cooperatively.
  11. [11]
    Calcium Oscillations - PMC - NIH
    Calcium signaling results from a complex interplay between activation and inactivation of intracellular and extracellular calcium permeable channels.
  12. [12]
    Frequency decoding of calcium oscillations - ScienceDirect
    Frequency modulation of Ca 2 + oscillations provides an efficient means to differentiate biological responses in the cell, both in health and in disease.
  13. [13]
    The SarcoEndoplasmic Reticulum Calcium ATPase (SERCA) pump
    Nov 12, 2021 · This review will focus on SERCA function and regulation mechanisms and describe how those mechanisms are affected under muscle pathological conditions.
  14. [14]
    The endoplasmic reticulum Ca2+ store: a view from the lumen.
    The endoplasmic reticulum (ER) and its specialized subcompartments such as the sarcoplasmic reticulum, is the main dynamic Ca2+ storage compartment of the cell.Missing: seminal papers<|control11|><|separator|>
  15. [15]
    Structure of IP3R Channel: High-resolution Insights from Cryo-EM
    This structure provided exciting mechanistic insights into the molecular assembly of IP 3 R, revealing the pronounced structural conservation of Ca 2+ release ...
  16. [16]
    Mechanistic basis of bell-shaped dependence of inositol 1,4,5 ... - NIH
    IP3 monotonically activates the IP3R channels at constant Ca2+ concentrations (10), but IP3 dynamically changes the Ca2+ sensitivity of the channel (11, 12).
  17. [17]
    Ryanodine Receptors: Structure, Expression, Molecular Details, and ...
    Ryanodine receptors (RyRs) are located in the sarcoplasmic/endoplasmic reticulum membrane and are responsible for the release of Ca2+ from intracellular stores ...
  18. [18]
    Sparks and Puffs in Oligodendrocyte Progenitors: Cross Talk ...
    Jun 1, 2001 · Sparks and puffs represent highly localized Ca2+ release from the ER through ryanodine receptors (RyRs) and inositol trisphosphate receptors (IP ...
  19. [19]
    Quantal Ca2+ release mediated by very few IP3 receptors that ...
    Nov 2, 2021 · We conclude, and test by simulations, that Ca 2+ signals evoked by IP 3 pulses arise from rapid activation and then inactivation of very few IP 3 Rs.
  20. [20]
    Voltage-Gated Calcium Channels - PMC - PubMed Central
    Voltage-gated calcium (Ca2+) channels are key transducers of membrane potential changes into intracellular Ca2+ transients that initiate many physiological ...
  21. [21]
    Ca2+ influx via the L-type Ca2+ channel during tail current and ... - NIH
    Ca2+ influx was readily detected by ΔFd beyond the ICa reversal potential (+65 to +100 mV) and was not abolished until Em was +120 mV (i.e. ECa). This is ...
  22. [22]
    Calcium-Dependent Inhibition of NMDA Receptor Currents
    Feb 6, 2024 · In this review, we focus on how NMDA receptors and calmodulin (CaM) collaborate to control calcium signaling in cells of the central nervous system (CNS).
  23. [23]
    Transient Receptor Potential Channels and Calcium Signaling - PMC
    TRP channels are tightly involved both in shaping Ca 2+ signals and in responding to physiological changes in intracellular Ca 2+ in animal cells.
  24. [24]
    The role of store-operated calcium influx in skeletal muscle signaling
    Store-operated calcium influx in skeletal muscle provides a pool of calcium necessary for signaling and activation of Ca 2+ -dependent gene expression.
  25. [25]
    Calcium Channel Blockers - StatPearls - NCBI Bookshelf
    Feb 22, 2024 · CCBs block the inward movement of calcium by binding to the L-type “long-acting” voltage-gated calcium channels in the heart, vascular smooth ...Continuing Education Activity · Indications · Mechanism of Action · Administration
  26. [26]
  27. [27]
    The Plasma Membrane Ca2+ ATPase and the Plasma ... - NIH
    The plasma membrane Ca 2+ ATPase (PMCA) and the plasma membrane Na + /Ca 2+ exchanger (NCX) are the two mechanisms responsible for Ca 2+ extrusion.
  28. [28]
    Cardiac Na+-Ca2+ Exchange | Circulation Research
    The Na+-Ca2+ exchanger (NCX) catalyzes electrogenic exchange of Na+ and Ca2+ across the plasma membrane in either the Ca2+-efflux or Ca2+-influx mode, ...
  29. [29]
  30. [30]
    Inositol trisphosphate and calcium signalling - Nature
    Review Article; Published: 28 January 1993. Inositol trisphosphate and calcium signalling. Michael J. Berridge. Nature volume 361, pages 315–325 (1993)Cite ...Missing: seminal paper
  31. [31]
    A molecular mechanism to diversify Ca2+ signaling downstream of ...
    Sep 3, 2024 · Our findings uncover the key steps of a previously unappreciated mechanism utilized by mammalian cells to finetune their calcium signaling regulation through ...
  32. [32]
    Structure, Function, and Control of Phosphoinositide-Specific ...
    Most notable is the realization that PLC-β, -γ, and -δ isoforms act in concert, each contributing to a specific aspect of the cellular response. Clues to their ...Abstract · Catalytic α/β-Barrel · C2 Domain · Carboxy-Terminal Extension
  33. [33]
    Structural basis for activation and gating of IP 3 receptors - Nature
    Mar 17, 2022 · Opening of the IP3Rs results in the rapid release of Ca2+ from the ER lumen into the cytoplasm, triggering diverse signaling cascades that ...
  34. [34]
    Inositol trisphosphate and calcium signalling - PubMed
    Inositol trisphosphate is a second messenger that controls many cellular processes by generating internal calcium signals.
  35. [35]
    IP3-mediated gating mechanism of the IP3 receptor revealed by ...
    Apr 17, 2017 · Inositol 1,4,5-trisphosphate (IP3) is a chemical signal that binds to the IP3 receptor (IP3R) to release calcium ions from the endoplasmic ...
  36. [36]
    Calcium signalling: IP3 rises again… and again - ScienceDirect
    IP3 receptor isoforms become more sensitive to IP3 as the Ca 2+ concentration is modestly increased, and they are then inhibited as the Ca 2+ concentration ...
  37. [37]
    Minimal requirements for calcium oscillations driven by the IP 3 ...
    Hormones and neurotransmitters that act through inositol 1,4,5‐trisphosphate (IP3) can induce oscillations of cytosolic Ca2+ ([Ca2+]c), which render dynamic ...
  38. [38]
    Calcium-induced release of calcium in muscle: 50 years of work and ...
    Mar 7, 2018 · Ryanodine-sensitive intracellular Ca2+ channels (RyRs) open upon binding Ca2+ at cytosolic-facing sites. This results in concerted, ...
  39. [39]
    FKBP12 Binding Modulates Ryanodine Receptor Channel Gating
    We now show that substitution of a Gly, Glu, or Ile for Val2461 in RyR1 prevents FKBP12 binding to RyR1, resulting in channels with increased gating frequency.
  40. [40]
    Ryanodine receptor binding to FKBP12 is modulated by channel ...
    Oct 15, 2005 · FKBP12 binding modifies RyR function by stabilising subunit interactions, eliminating subconductance states and decreasing the open probability ...
  41. [41]
    Ryanodine receptor-mediated arrhythmias and sudden cardiac death
    This review centres upon the role of the cardiac RyR2 isoform in arrhythmia and SCD. RyR2 dysfunction manifested as tachyarrhythmias is triggered by physical or ...
  42. [42]
    STIM AND ORAI, THE LONG AWAITED CONSTITUENTS OF ... - NIH
    A widely utilized form of Ca 2+ influx is termed store-operated Ca 2+ entry (SOCE) due to its control by the Ca 2+ content of the endoplasmic reticulum (ER).Missing: seminal papers
  43. [43]
    STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered ...
    Jul 12, 2005 · Our study suggests that STIM proteins function as Ca(2+) store sensors in the signaling pathway connecting Ca(2+) store depletion to Ca(2+) influx.
  44. [44]
    A mutation in Orai1 causes immune deficiency by abrogating CRAC ...
    Article; Published: 02 April 2006. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Stefan Feske,; Yousang Gwack, ...
  45. [45]
    STIM1 gates the store-operated calcium channel ORAI1 in vitro - PMC
    These experiments show that the STIM1-ORAI1 interaction is sufficient to gate recombinant human ORAI1 channels in the absence of other proteins of the human ...Missing: seminal discovery
  46. [46]
    Depletion of intracellular calcium stores activates a ... - PubMed
    Jan 23, 1992 · This Ca2+ current, which we term ICRAC (calcium release-activated calcium), is not voltage-activated and shows a characteristic inward ...
  47. [47]
    Store-operated calcium entry: mechanisms and modulation - PMC
    Abstract. Store-operated calcium entry is a central mechanism in cellular calcium signalling and in maintaining cellular calcium balance.Missing: seminal | Show results with:seminal
  48. [48]
    Selective Activation of the Transcription Factor NFAT1 by Calcium ...
    We visualize NFAT1 movement in and out of the nucleus in response to transient activation of store-operated Ca 2+ release-activated Ca 2+ (CRAC) channels in ...
  49. [49]
    2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store ...
    2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release.
  50. [50]
    Excitation-contraction coupling in skeletal muscle - PubMed Central
    Jan 16, 2020 · Excitation-contraction coupling (ECC) is a physiological process that links excitation of muscles by the nervous system to their mechanical contraction.
  51. [51]
    The excitation–contraction coupling mechanism in skeletal muscle
    In skeletal muscle, the RyR1 and the DHPR are in close apposition, constituting the Ca2+ release units (CRU), that are activated almost simultaneously as a ...
  52. [52]
  53. [53]
  54. [54]
    Regulation of excitation-contraction coupling in mouse cardiac ...
    Aug 31, 2009 · This conclusion is supported by the fact that the fractional release is reduced by 40% from 0.28 to 0.17 in silico. In the model with CaMK ...
  55. [55]
    SARCOLIPIN AND PHOSPHOLAMBAN AS REGULATORS OF ...
    Phosphorylation of SLN by CAMKII relieves the inhibitory effect of SLN on SERCA2a in the atria, activating SERCA2a leading the atrial muscle relaxation.
  56. [56]
  57. [57]
  58. [58]
    The molecular basis of the steep force–calcium relation in heart ...
    The force–calcium relation (squares) can be fitted by the Hill equation ... A troponin switch that regulates muscle contraction by stretch instead of calcium.
  59. [59]
    The hill coefficient for the Ca2+-activation of striated muscle ... - NIH
    Systems operating at nonequilibrium stationary states are known to display Hill coefficients greater than the number of interacting sites and similar results ...
  60. [60]
    Roles of N-Type and Q-Type Ca2+ Channels in Supporting ...
    Synaptic transmission between hippocampal CA3 and CA1 neurons was mediated by N-type calcium channels, together with calcium channels whose pharmacology differs ...Missing: NP/ | Show results with:NP/
  61. [61]
    Long-Term Potentiation: From CaMKII to AMPA Receptor Trafficking
    Feb 10, 2016 · For more than 20 years, we have known that Ca2+/calmodulin-dependent protein kinase (CaMKII) activation is both necessary and sufficient for the ...
  62. [62]
    Calcium signaling in mammalian egg activation and embryo ... - NIH
    In this review, which focuses on mammalian egg activation, we consider how Ca 2+ is regulated and stored at different stages of oocyte development.Calcium Signaling In... · Egg Activation Overview · Calcium Signaling During...
  63. [63]
  64. [64]
  65. [65]
    Modulators of calcium signalling at fertilization | Open Biology
    Jul 15, 2020 · We discuss here the molecular basis for modulation of Ca 2+ signalling at fertilization, highlighting differences across several animal phyla.
  66. [66]
  67. [67]
    Comparative Biology of Calcium Signaling during Fertilization and ...
    This paper reviews the spatiotemporal properties of calcium signaling during fertilization and egg activation in marine invertebrates and compares these ...
  68. [68]
    The Role of Calcium–Calcineurin–NFAT Signaling Pathway in ...
    CRAC channels are the main routes of Ca2+ entry in non-excitable cells, especially immune cells. When intracellular Ca2+ stores are decreased, store-operated Ca ...
  69. [69]
    Calcium signalling in T cells - PMC - PubMed Central - NIH
    In this article, we review the expression and function of various Ca2+-permeable channels in the plasma membrane, endoplasmic reticulum, mitochondria and ...
  70. [70]
    Transcriptional regulation by calcium, calcineurin, and NFAT
    NFAT activation is initiated by dephosphorylation of the NFAT regulatory domain, a conserved ∼300-amino-acid region located N-terminal to the DNA-binding domain ...
  71. [71]
    NFAT and NFκB Activation in T Lymphocytes: A Model of Differential ...
    Oct 10, 2006 · An increasing calcium concentration activates calcineurin (C), which binds to and dephosphorylates NFAT:Pi (dark gray box). The NFAT-activated ...
  72. [72]
    CREB: a Ca2+-Regulated Transcription Factor Phosphorylated by ...
    The mechanism by which Ca2+ mediates gene induction in response to membrane depolarization was investigated. The adenosine 3′,5′-monophosphate (cAMP) ...
  73. [73]
    Coupling of Ca2+ to CREB Activation and Gene Expression in Intact ...
    Inhibition of Ca2+/calmodulin-dependent protein kinase (CaM kinase) blocked increases in P-CREB and c-fos levels seen with membrane depolarization, suggesting ...Missing: CaMK cancer
  74. [74]
    Calmodulin-dependent phosphatase, kinases, and transcriptional ...
    The second messenger calcium plays an essential role in mediating the TCR signaling pathway leading to cytokine production and T cell clonal expansion.Missing: cancer | Show results with:cancer
  75. [75]
    The Multi-Functional Calcium/Calmodulin Stimulated Protein Kinase ...
    The CaMK family members, particularly CaMKII, are attractive anti-cancer targets as they are overexpressed in a plethora of cancer types.Missing: fos | Show results with:fos
  76. [76]
    The frequencies of calcium oscillations are optimized for ... - PNAS
    May 24, 2005 · Here, we show that Ca2+ oscillations are optimized for Ca2+-mediated activation of Ras and signaling through the extracellular signal-regulated ...
  77. [77]
    Ca2+ oscillation frequency regulates agonist-stimulated gene ...
    Aug 1, 2008 · This study shows that [Ca2+]i oscillation frequency cooperates with ROS to efficiently regulate agonist-stimulated gene expression, and provides ...
  78. [78]
    Calcium oscillations in mesenchymal stem cells, a control on cell ...
    Aug 21, 2025 · Ca2+ oscillations are known to encode important information in frequency and amplitude, ultimately controlling many cellular processes such as ...
  79. [79]
    Impact of β-Amyloids Induced Disruption of Ca2+ Homeostasis ... - NIH
    Feb 10, 2022 · Alzheimer's disease is characterized by a marked dysregulation of intracellular Ca2+ homeostasis. In particular, toxic β-amyloids (Aβ) perturb ...
  80. [80]
    Dysregulation of Neuronal Calcium Signaling via Store-Operated ...
    In HD models, the dysregulation of Ca2+ release from the ER by RyR signaling was also observed.
  81. [81]
    RYR2 Variants in Catecholaminergic Polymorphic Ventricular ...
    Aug 26, 2025 · CPVT is caused by pathogenic variants in the cardiac type 2 ryanodine receptor gene, RYR2, or the sarcoplasmic reticulum protein calsequestrin ...
  82. [82]
    Reduced expression of PMCA1 is associated with increased blood ...
    Genomewide association studies have linked ATP2B1, the gene for the plasma membrane calcium ATPase 1 (PMCA1), to blood pressure (BP) and hypertension. Here, we ...
  83. [83]
    SOCE and cancer: Recent progress and new perspectives
    Sep 10, 2015 · 82 (ii) SOCE blockade through STIM1 or ORAI1 knockdown impairs focal adhesion turnover and cell migration.66, 76, 79 Aberrant SOCE causes ...Role Of Soce In Cancer · Soce Regulates Tumor... · Anti-Orai1 Monoclonal...
  84. [84]
    TRP channels in cancer: Therapeutic opportunities and research ...
    This review explores the multifaceted roles of TRP channels in oncogenesis and emphasizes their significance in cancer progression and therapeutic outcomes.
  85. [85]
    (PDF) A mutation in Orai1 causes immune deficiency by abrogating ...
    Aug 9, 2025 · A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. June 2006; Nature 441(7090):179-85. DOI:10.1038/nature04702.
  86. [86]
    Store-Operated Calcium Channels as Drug Target in ... - NIH
    May 3, 2021 · RP4010 from Rhizen Pharmaceuticals is another selective SOCE channel inhibitor. Due to its low toxicity and high solubility, it has been ...
  87. [87]
    Diltiazem - StatPearls - NCBI Bookshelf - NIH
    It is used in many clinical scenarios as an antihypertensive, anti-arrhythmic, and anti-anginal. FDA-approved indications include atrial arrhythmia, ...Continuing Education Activity · Indications · Mechanism of Action · Administration
  88. [88]
    Nimodipine - StatPearls - NCBI Bookshelf
    May 7, 2024 · Today, nimodipine is predominantly used to manage vasospasm subsequent to subarachnoid hemorrhage, in addition to off-label applications.Continuing Education Activity · Indications · Mechanism of Action · Administration
  89. [89]
    Anti‐ORAI1 antibody DS‐2741a, a specific CRAC channel blocker ...
    These results clearly indicate that ORAI1 is an important target for the treatment of diseases associated with T‐ and/or mast cell activation and that DS‐2741a ...Missing: disorders | Show results with:disorders
  90. [90]
    Targeting thapsigargin towards tumors - PubMed - NIH
    By inhibiting the sarco/endoplasmic reticulum Ca(2+) ATPase (SERCA) thapsigargin provokes apoptosis in almost all cells. By conjugating thapsigargin to peptides ...
  91. [91]
    Istaroxime and Beyond: New Therapeutic Strategies to Specifically ...
    Istaroxime and Beyond: New Therapeutic Strategies to Specifically Activate SERCA and Treat Heart Failure.Missing: clinical trials
  92. [92]
    A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock ...
    The current trial aims to assess the effect of istaroxime in patients with SCAI Stage C Cardiogenic Shock (CS). These patients look unwell, frequently with ...
  93. [93]
    In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic ... - NIH
    This work highlights the potential of somatic genome editing approaches for the treatment of lethal autosomal-dominant inherited cardiac disorders such as CPVT.
  94. [94]
    Phospholipase Cζ, the Molecular Spark of Fertilization and Male ...
    May 23, 2025 · Phospholipase C zeta (PLCζ) has emerged as a pivotal sperm-specific factor responsible for triggering oocyte activation, a process essential for successful ...5. Therapeutic Approaches · 5.1. Assisted Oocyte... · 6. Future Directions